News
Dopamine modulates the reward experiences elicited by music
A new study published in Proceedings of the National Academy of Science (PNAS), reveals a causal link between dopamine and the reward responses in humans when listening to music. The study was conducted by researchers from the Cognition and Brain Plasticity Group of the University of Barcelona and the Bellvitge Biomedical Research Institute of Bellvitge […]
IDIBELL researchers identify a new leukodystrophy in children and its potential cure
The gene that causes the disease is called DEGS1 and its defect may be counteracted with fingolimod, a drug currently used to treat multiple sclerosis
IDIBELL and Bellvitge University Hospital develop a new treatment to fight against hospital infections
The new treatment would prevent more than 4 million patients admitted to the Intensive Care Units (ICU) worldwide from developing infections that need antibiotics
An intellectually active lifestyle protects against neurodegeneration in people with Huntington’s disease
The discovery reinforces the importance of leading a cognitively stimulating life to maintain a healthy brain
Researchers identify a new therapeutic target for metastatic and resistant prostate cancers
Researchers identify a new therapeutic target for metastatic and resistant prostate cancers
Ruth Rodríguez Barrueco, L’Oréal-UNESCO Research Award “For Women in Science”
IDIBELL – University of Barcelona researcher Ruth Rodríguez Barrueco has been awarded one of the five L’Oréal-UNESCO Research Awards “For Women in Science” in its 2018-19 call. The award, worth € 15,000, will support and promote the project carried out by Dr. Rodríguez-Barrueco, which focuses on the discovery of new targets for breast cancer treatment. Breast […]
The ‘Viladecans Against Cancer’ Association Coordinator raises 20.000 euros for research on metastasis of unknown origin cancer in IDIBELL
During the course of an open ‘paella’ that brought together eight hundred people in the Cúbic space of Viladecans, the Association Viladecans Against Cancer officially offered a 20,000 euros check to IDIBELL for the investigation of a new treatment for cancer metastasis of unknown origin, led by Dr. Manel Esteller (Epigenetics and Cancer Biology program […]
Scientists unveil the mechanism of action of the key gene for the formation of blood vessels involved in cancer and vascular malformations
The detailed description of the biology of the PIK3CA gene has allowed to understand how venous malformations and other overgrowth disorders, such as cancer, develop.